Craig A. Tooman

2009 - Enzon Pharmaceuticals

In 2009, Craig A. Tooman earned a total compensation of $680.6K as Former Vice President, Finance and Chief Financial Officer at Enzon Pharmaceuticals, a 55% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$137,500
Salary$505,000
Other$38,055
Total$680,555

Tooman received $505K in salary, accounting for 74% of the total pay in 2009.

Tooman also received $137.5K in non-equity incentive plan and $38.1K in other compensation.

Rankings

In 2009, Craig A. Tooman's compensation ranked 5,782nd out of 9,885 executives tracked by ExecPay. In other words, Tooman earned more than 41.5% of executives.

ClassificationRankingPercentile
All
5,782
out of 9,885
42nd
Division
Manufacturing
2,083
out of 3,690
44th
Major group
Chemicals And Allied Products
443
out of 866
49th
Industry group
Drugs
289
out of 638
55th
Industry
Biological Products, Except Diagnostic Substances
51
out of 133
62nd
Source: SEC filing on April 8, 2011.

Tooman's colleagues

We found five more compensation records of executives who worked with Craig A. Tooman at Enzon Pharmaceuticals in 2009.

2009

Jeffrey Buchalter

Enzon Pharmaceuticals

Chief Executive Officer

2009

Ivan Horak

Enzon Pharmaceuticals

Chief Scientific Officer

2009

Ralph del Campo

Enzon Pharmaceuticals

Chief Operating Officer

2009

Paul Davit

Enzon Pharmaceuticals

Executive Vice President, Human Resources and Administration

2009

Mark Ogden

Enzon Pharmaceuticals

Acting Vice President, Finance and Principal Financial Officer

News

You may also like